NovaBay Pharmaceuticals Inc (NBY) FY2024Q3 Earning Prediction
NovaBay Pharmaceuticals Inc (NBY) is set to release its earnings performance on 11/07 ET in trading. Consensus forecasts predict a revenue of 2.63M and an earnings per share (EPS) of -0.28 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
NBY Transcript
The earnings call presents a mixed picture: slight revenue growth and improved margins are offset by significant net losses and challenges in the capital market. The Q&A reveals strategic shifts in marketing and reliance on partnerships, but lacks clarity on EU sales reporting. The absence of new R&D investments is offset by partnership-driven innovation. Despite cost reductions, the financial health remains strained. Without clear guidance or major positive catalysts, the stock reaction is likely to remain neutral.
NBY Report
Frequently Asked Questions
What is the NovaBay Pharmaceuticals Inc FY2024Q3 Earnings Release Date and Time?
NovaBay Pharmaceuticals Inc (NBY) is scheduled to release its FY2024Q3 earnings report onNov 7, 2024, (approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for NovaBay Pharmaceuticals Inc FY2024Q3 Revenue and EPS?
Analysts' consensus predicts 2.63M in revenue and an EPS of -0.28 for NovaBay Pharmaceuticals Inc's FY2024Q3.
What Does Intellectia's AI Predict for NovaBay Pharmaceuticals Inc FY2024Q3 Earnings?
Intellectia's exclusive AI algorithms forecast a forNovaBay Pharmaceuticals Inc's FY2024Q3 earnings, with a prediction date of Nov 7, 2024. NovaBay Pharmaceuticals Inc
How Can I Use This Earnings Prediction to Trade NBY Stock?
Leverage Intellectia's AI forecast to position trades ahead of theNov 7, 2024 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like NovaBay Pharmaceuticals Inc FY2024Q3?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
